Our investigation focused on RAC1, as it has been widely observed that its alternative splicing leads to RAC1B, a constitutive-active Ran GTPases which has been found to stimulate cancer cell proliferation, enhance epithelial-mesenchymal transition (EMT), and induce drug resistance [17]. This evidence concerns the gene RAN and cancer.